InvestorsHub Logo
Followers 28
Posts 1715
Boards Moderated 0
Alias Born 02/07/2021

Re: None

Sunday, 06/05/2022 9:59:10 AM

Sunday, June 05, 2022 9:59:10 AM

Post# of 157
Saw this coming !!



Unity Biotechnology (UBX) Receives a Buy from Mizuho Securities

Source: TipRanks
In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on Unity Biotechnology (UBX – Research Report), with a price target of $7.00. The company's shares closed last Thursday at $0.77, close to its 52-week low of $0.70. According to TipRanks.com, Syed 's ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -17.5% and a 34.9% success rate. Syed covers the Healthcare sector, focusing on stocks such as Atara Biotherapeutics, Assembly Biosciences, and Coherus Biosciences. Currently, the analyst consensus on Unity Biotechnology is a Strong Buy with an average price target of $7.00.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent UBX News